Excited to be a panelist alongside Jason Rolfe, Lindsay Pino, and Rao Talasila to dicuss AI in biotech hosted by Madrona, Google, Cooley LLP, Alexandria Real Estate Equities, Inc., and J.P. Morgan Private Bank. At Vilya we are excited to be at the cutting edge of AI in drug discovery. Looking forward to discussing this and more during the panel on April 17th.
Patrick Salveson, Ph.D.’s Post
More Relevant Posts
-
"On the 4th day of Celent Insights..." Patrick Wegner, Celent's Capital Markets Senior Analyst, dives into #GenAI in the Capital Markets space. Discover how the industry has grappled with implementing GenAI, the impact of recent developments, and the key challenges, including data security and bias, facing the industry > https://lnkd.in/e6vEfzHy
To view or add a comment, sign in
-
Exciting news! Edward Hoang, our newest Equity Research Analyst at Atlasio Capital Partners, has written a Case Study of NVIDIA Corporation and Financial Sector Adoption as part of the Impacts of AI on Global Economies and Markets. Please make sure to have a read and huge thanks to Edward Hoang!
To view or add a comment, sign in
-
‼️ EWPN SEE Conference Debate Club: "Powering the A(I)nnovation!" A discussion on AI's role in shaping the future versus its real-world applications today. 🎤 Meet our moderator, Jovana (Marković) Vidaković,, and our dynamic teams: Team A: Dino Selimbasic, Amina Karic, and MAJA FOČIĆ. Team B: Gjergji Guri, Ana Brajkovic Ladjarevic and Nermina Agović-Kaliman. ✔️ Team A champions AI as the vision of the future, emphasizing its transformative potential across industries, particularly in finance and healthcare. Discover how AI streamlines processes, empowers creativity, and reshapes the labor market. ✔️ Team B brings a pragmatic perspective, exploring the challenges and risks associated with current AI implementations. From outsourcing technologies to transparency issues and the evolving nature of AI development, delve into the realities of integrating AI into business operations today.
To view or add a comment, sign in
-
AI integration across processes is expected to increase over the next 2-3 years as LPs recognise potential growth in AI-driven solutions. Discover more key takeaways from the 39th Coller Capital Global Private Equity Barometer on our website: https://ow.ly/kv8f50QjcF2 #privateequity #privatemarkets #limitedpartners #alternativeassets #collerbarometer
Coller Capital shares its 39th Global Private Equity Barometer
To view or add a comment, sign in
-
I'll help you do more with less, avoid blind spots & access insights 55% quicker with proprietary content.
Make deal decisions faster with the right information on AlphaSense - Get answers faster with AI search & summarization - Spend less time extracting financials from company filings - Access market outlooks from all of the world’s top banks Read more below 👇 👇👇
Due Diligence
https://www.alpha-sense.com
To view or add a comment, sign in
-
Our latest newsletter is ready for you! In this month's edition OVF partner Deepthi Madhava caught up with Tracy Camp to learn more about what he, Svetoslav Vassilev and the UpSight Security Inc. team are working on - spoiler alert: they are fighting bad AI with good AI and it's not only innovative, it's impactful. We also welcome Pacific University to the OVF family of investors and provide insight into the impact they are making. Welcome! You'll also find some exciting updates on a few of our portfolio companies including Sila (Shamir Karkal), Gutsy (John Morello) and Salt & Straw (Kim Malek). As well as insight on our recent annual meeting and what happens when you bring a group of local institutional investors together in one space. Our May newsletter can be found here: https://conta.cc/3UJDT29 If you're one of the literal 1000s who have signed up to receive our newsletter directly, it was delivered to your inbox last week. If you're not already receiving our monthly newsletter directly, never fear - you too can be one of the first to learn more about what's happening in PNW venture capital and/or the impact our portfolio companies are making - just sign up to receive our newsletter directly at: https://lnkd.in/gbacyKiN We promise to always keep it short and informative. Eric Rosenfeld Matt Compton Jon Maroney Lynn Fletcher Gloria Zabel Melissa (Durham) Freeman Mary Geyer #oregoninnovation #InvestingLocallyScalingGlobally #ourportfoliocompaniesrock
Using Good AI Against Bad AI - May 2024
myemail-api.constantcontact.com
To view or add a comment, sign in
-
Over the last six months, my conversations with health plan leaders, colleagues, and technology partners have increased exponentially. On March 14, I am joining a panel discussing emerging AI opportunities for health plans at the BWG Strategy's Future of AI Conference. One area of interest I am tracking is how AI will enable increased industry capability convergence in the Health Plan and Banking/Financial Services space. https://lnkd.in/efpnyxsd
The Future of AI Conference presented by BWG Strategy and OTR Global
https://bwgstrategy.com
To view or add a comment, sign in
-
In the first Iron Man movie, Obadiah Stane, the bad guy in case you haven’t watched it, berates his scientists for struggling to build an arc reactor, the technology that powers Iron Man’s suit. Jabbing his finger into the chief scientists’s chest, Obadiah screams into the poor man’s face. “Tony Stark was able to build this in a cave! With a box of scraps!” To which the hapless scientist replies, “I’m sorry. I’m not Tony Stark”. As we engage more openly with the market and think more intentionally about product-market fit, we’re seeing many mid-market corporates weighed down by lots of operational and technical debt. In other words, they struggle with seemingly simple stuff that’s become extraordinarily difficult to do. It’s not hard to imagine managers in these companies coming out of a meeting with their boss and muttering under their breath, “I’m sorry, I’m not Tony Stark.” The challenge for me and my colleagues at The AI Shop is to decide: - Do we have a product that can help them? The answer is sometimes yes. - Can we build a product that can help them? The answer is usually yes. - Should we build a product that can help them? The answer is usually no. Sometimes an organisation needs to fix its core processes before any new tech can really come into its own. And as Jensen Huang the co-founder of Nvidia said in a recent interview at Stanford, and I’m paraphrasing here, it’s ok if we don’t try to fix every problem we come across. We’ve just got to focus on what we’ve chosen to be extraordinarily good at. Enjoy.
Obadiah Stane and a scientist for stark industries
https://www.youtube.com/
To view or add a comment, sign in
-
Sponsoring the ACGSV C-Circle event was an excellent opportunity to shine a light on the economic outlook for 2024. 🔦 Moderated by Andy Armstrong, the panel discussion delved into the challenges of 2023 and the promising opportunities that await in 2024. Key insights were shared by panelists Susan Winter, Bronwyn Bailey and Chris Combs, guiding us through what to expect this year, including: 🔑 Signs are pointing towards a strong recovery. 🔑 The market is buzzing with pent-up demand after a somewhat lackluster 2023, and investments are on the rise in growth sectors like AI, tech and business services. 🔑 Life sciences are dominating the IPO landscape, but AI and tech are not far behind. 🔑 Many companies will fall off and need to wind down as funding purse strings are still tight. Huge thanks to JPMorgan for hosting this enlightening event and to everyone who joined and contributed to the thought-provoking discussion. #IPO #AI #LifeSciences #Tech #EconomicOutlook
To view or add a comment, sign in
-
Sponsoring the ACGSV C-Circle event was an excellent opportunity to shine a light on the economic outlook for 2024. 🔦 Moderated by Andy Armstrong, the panel discussion delved into the challenges of 2023 and the promising opportunities that await in 2024. Key insights were shared by panelists Susan Winter, Bronwyn Bailey and Chris Combs, guiding us through what to expect this year, including: 🔑 Signs are pointing towards a strong recovery. 🔑 The market is buzzing with pent-up demand after a somewhat lackluster 2023, and investments are on the rise in growth sectors like AI, tech and business services. 🔑 Life sciences are dominating the IPO landscape, but AI and tech are not far behind. 🔑 Many companies will fall off and need to wind down as funding purse strings are still tight. Huge thanks to JPMorgan for hosting this enlightening event and to everyone who joined and contributed to the thought-provoking discussion. #IPO #AI #LifeSciences #Tech #EconomicOutlook
To view or add a comment, sign in
Co-Founder and CTO at Talus Bio (YC S21) - nothing is undruggable - unlocking transcription factors with functional proteomics and genomics
5moThanks for the great discussion, I learned so much!